Showing results (1-10 of 2,168) with videos related to
Sort By:
Pageof 217
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|January 13, 2021
[Cutaneous angiosarcoma clinically presenting as Quincke's edema]M Albrecht, E Hadaschik, L Zimmer, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Management of partial and non-responding cutaneous squamous cell carcinomaP Jansen, G C Lodde, K G Griewank, et al.Der Internist|May 29, 2020
[Immunotherapy for malignant melanoma]A Zaremba, L Zimmer, K G Griewank, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Advances and perspectives in immunotherapy of melanomaD Schadendorf, J Vaubel, E Livingstone, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 16, 2014
Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rashJ Vaubel, E Livingstone, D Schadendorf, et al.Deutsche Medizinische Wochenschrift (1946)|December 25, 2010
[Interdisciplinary management of cutaneous adverse events of EGFR inhibitors and multityrosine kinase inhibitors in oncology]E Livingstone, T Trarbach, L Zimmer, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitorsP Jansen, G C Lodde, A Wetter, et al.Onkologie|July 8, 2003
Systemic treatment in advanced melanoma: innovative perspectivesS Ugurel, D SchadendorfDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 26, 2012
[Immunotherapy of melanomas]L Zimmer, J Vaubel, D SchadendorfBritish Journal of Cancer|April 17, 2003
Dose-dependent severe cutaneous reactions to imatinibS Ugurel, R Hildenbrand, E Dippel, et al.Pageof 217